Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 14, 2021. Long positions only.
- Positions
- 62
- No 13F data for Q4 2020
- Portfolio value
- $204.0M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BBIOBridgeBio Pharma, Inc. | COM | 577,500 | $35.6M | 17.4% | – | – | History |
| MORFMorphic Holding, Inc. | COM | 195,000 | $12.3M | 6.0% | – | – | History |
| CRISCuris Inc | COM NEW | 1,000,000 | $11.3M | 5.5% | – | – | History |
| VINCVincerx Pharma, Inc. | COM NEW | 543,010 | $10.5M | 5.1% | – | – | History |
| KURAKura Oncology, Inc. | COM | 365,000 | $10.3M | 5.1% | – | – | History |
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 689,000 | $9.49M | 4.7% | – | – | – |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 700,000 | $7.33M | 3.6% | – | – | History |
| XLRNAcceleron Pharma Inc | COM | 45,000 | $6.10M | 3.0% | – | – | History |
| ACRSAclaris Therapeutics, Inc. | COM | 222,267 | $5.60M | 2.7% | – | – | History |
| TVTXTravere Therapeutics, Inc. | COM | 220,000 | $5.49M | 2.7% | – | – | History |
| NARIInari Medical, Inc. | Stock | 50,000 | $5.35M | 2.6% | – | – | History |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $4.07M | 2.0% | – | – | – |
| SNCEScience 37 Holdings, Inc. | COM | 400,000 | $4.06M | 2.0% | – | – | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 85,000 | $3.77M | 1.8% | – | – | History |
| OCULOcular Therapeutix, Inc | COM | 227,500 | $3.73M | 1.8% | – | – | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 270,000 | $3.71M | 1.8% | – | – | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 300,000 | $3.56M | 1.7% | – | – | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 77,500 | $3.36M | 1.6% | – | – | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 35,000 | $3.22M | 1.6% | – | – | History |
| MREOMereo BioPharma Group plc | SPON ADS | 900,000 | $3.03M | 1.5% | – | – | History |
| Medicus Sciences AcquisitionG5960S116 | UNIT 99/99/9999 | 300,000 | $2.96M | 1.4% | – | – | – |
| KDNYChinook Therapeutics, Inc. | COM | 175,000 | $2.72M | 1.3% | – | – | History |
| Bio Green Med Solution, Inc.23254L603 | COM | 380,000 | $2.70M | 1.3% | – | – | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 130,000 | $2.68M | 1.3% | – | – | History |
| EPIXESSA Pharma Inc. | COM NEW | 90,000 | $2.62M | 1.3% | – | – | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 20,000 | $2.58M | 1.3% | – | – | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 100,000 | $2.57M | 1.3% | – | – | History |
| ZYMEZymeworks Inc. | COM | 80,000 | $2.53M | 1.2% | – | – | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 225,000 | $2.52M | 1.2% | – | – | History |
| LUNGPulmonx Corp | COM | 45,000 | $2.06M | 1.0% | – | – | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 27,000 | $1.99M | 1.0% | – | – | History |
| STROSutro Biopharma, Inc. | COM | 80,000 | $1.82M | 0.9% | – | – | History |
| Highcape Cap Acquisition Cor42984L105 | COM CL A | 150,000 | $1.79M | 0.9% | – | – | – |
| BFLYButterfly Network, Inc. | COM CL A | 100,000 | $1.68M | 0.8% | – | – | History |
| MRSNMersana Therapeutics, Inc. | COM | 85,000 | $1.38M | 0.7% | – | – | History |
| PTGXProtagonist Therapeutics, Inc | COM | 50,000 | $1.29M | 0.6% | – | – | History |
| Bellus Health Inc New07987C204 | COM NEW | 300,000 | $1.15M | 0.6% | – | – | – |
| BCTG Acquisition Corp05492W103 | COM | 100,000 | $1.11M | 0.5% | – | – | – |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 12,500 | $964.0K | 0.5% | – | – | History |
| CYTKCytokinetics Inc | COM NEW | 40,000 | $930.0K | 0.5% | – | – | History |
| Vincerx Pharma, Inc.92731L114 | *W EXP 12/24/202 | 218,000 | $881.0K | 0.4% | – | – | – |
| GBTGlobal Blood Therapeutics, Inc. | COM | 20,000 | $815.0K | 0.4% | – | – | History |
| AFIBAcutus Medical, Inc. | COM | 60,000 | $802.0K | 0.4% | – | – | History |
| MGNXMacrogenics Inc | COM | 25,000 | $796.0K | 0.4% | – | – | History |
| Chardan Healthcr Acqstn 2 Co15957T206 | UNIT 99/99/9999 | 75,000 | $789.0K | 0.4% | – | – | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 24,600 | $779.0K | 0.4% | – | – | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 20,000 | $740.0K | 0.4% | – | – | History |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 200,000 | $670.0K | 0.3% | – | – | – |
| XFORX4 Pharmaceuticals, Inc | COM | 75,000 | $646.0K | 0.3% | – | – | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 10,000 | $625.0K | 0.3% | – | – | History |
| PCVXVaxcyte, Inc. | COM | 30,000 | $593.0K | 0.3% | – | – | History |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 200,000 | $590.0K | 0.3% | – | – | – |
| AXSMAxsome Therapeutics, Inc. | COM | 10,000 | $566.0K | 0.3% | – | – | History |
| BYSIBeyondSpring Inc. | SHS | 50,000 | $554.0K | 0.3% | – | – | History |
| EPZMEpizyme, Inc. | COM | 50,000 | $436.0K | 0.2% | – | – | History |
| HARPHarpoon Therapeutics, Inc. | COM | 20,000 | $418.0K | 0.2% | – | – | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 25,000 | $414.0K | 0.2% | – | – | – |
| CTMXCytomX Therapeutics, Inc. | COM | 50,000 | $387.0K | 0.2% | – | – | History |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 72,466 | $312.0K | 0.2% | – | – | – |
| WINTWindtree Therapeutics Inc | COM | 42,847 | $105.0K | 0.1% | – | – | History |
| Vesper Healthcare Acqstn Cor92538T112 | *W EXP 09/30/202 | 45,000 | $94.0K | <0.1% | – | – | – |
| ZYNEZynerba Pharmaceuticals, Inc. | COM | 13,285 | $62.0K | <0.1% | – | – | History |
Options (10)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $43.6M | – |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | $21.3M | – |
| VRTXVertex Pharmaceuticals Inc | Stock | – | $10.7M |
| SNDXSyndax Pharmaceuticals Inc | COM | – | $4.26M |
| CRISCuris Inc | COM NEW | – | $2.83M |
| ASNDAscendis Pharma A/S | SPONSORED ADR | $2.58M | – |
| RUBYRubius Therapeutics, Inc. | COM | – | $1.85M |
| BLUEbluebird bio, Inc. | COM | – | $1.51M |
| IMVTImmunovant, Inc. | COM | – | $1.12M |
| MRNAModerna, Inc. | Stock | – | $655.0K |